Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.

Journal article

Esposito I. et al, (2020), Science translational medicine, 12

Impairment of CD8 T cell memory in DAA treated HCV/HIV co-infected patients

Conference paper

Hoffmann M. et al, (2019), HIV MEDICINE, 20, 36 - 36

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection.

Journal article

Zilber E. et al, (2019), AIDS (London, England), 33, 1253 - 1256

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

Journal article

López-Camacho C. et al, (2018), Nature Communications, 9

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers

Journal article

Rosás-Umbert M. et al, (2018), Journal of Virology, 93

LBP-002: Novel ImmTAV molecules for the treatment of HBV

Conference paper

(2018), Journal of Viral Hepatitis, 25, 194 - 194

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

Journal article

Martin GE. et al, (2018), Frontiers in Immunology, 9

Therapeutic HPV vaccines

Journal article

Hancock G. et al, (2018), Best Practice & Research Clinical Obstetrics & Gynaecology, 47, 59 - 72

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.

Journal article

Yang H. et al, (2018), Front Immunol, 9

Pathophysiology of ischaemic heart disease

Journal article

Pocock MO. et al, (2017), Current Opinion in HIV and AIDS, 1 - 1

Load More